Małgorzata Siger

607 total citations
22 papers, 403 citations indexed

About

Małgorzata Siger is a scholar working on Pathology and Forensic Medicine, Rheumatology and Ophthalmology. According to data from OpenAlex, Małgorzata Siger has authored 22 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pathology and Forensic Medicine, 7 papers in Rheumatology and 4 papers in Ophthalmology. Recurrent topics in Małgorzata Siger's work include Multiple Sclerosis Research Studies (15 papers), Systemic Lupus Erythematosus Research (5 papers) and Systemic Sclerosis and Related Diseases (5 papers). Małgorzata Siger is often cited by papers focused on Multiple Sclerosis Research Studies (15 papers), Systemic Lupus Erythematosus Research (5 papers) and Systemic Sclerosis and Related Diseases (5 papers). Małgorzata Siger collaborates with scholars based in Poland and United States. Małgorzata Siger's co-authors include Krzysztof Selmaj, K Dziegielewski, Jerzy Nawrocki, Agata Walczak, Marian Szczepanik, Michael W. Weiner, Norbert Schuff, Xiaoping Zhu, Bruce L. Miller and Mariusz Stasiołek and has published in prestigious journals such as International Journal of Molecular Sciences, Sensors and Journal of the Neurological Sciences.

In The Last Decade

Małgorzata Siger

19 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Małgorzata Siger Poland 7 218 127 79 76 68 22 403
Jens Harmel Germany 9 385 1.8× 253 2.0× 258 3.3× 140 1.8× 75 1.1× 15 629
Jeffrey Lambe United States 11 211 1.0× 119 0.9× 88 1.1× 102 1.3× 19 0.3× 22 325
Kim Lea Young Germany 11 262 1.2× 140 1.1× 66 0.8× 80 1.1× 5 0.1× 13 410
Petra Nytrová Czechia 11 328 1.5× 26 0.2× 233 2.9× 118 1.6× 75 1.1× 27 453
Janine Mikolajczak Germany 11 172 0.8× 259 2.0× 98 1.2× 63 0.8× 8 0.1× 13 429
José Antonio Cabrera-Gómez Cuba 9 446 2.0× 39 0.3× 318 4.0× 156 2.1× 47 0.7× 21 517
Magdolna Simó Hungary 11 90 0.4× 64 0.5× 132 1.7× 37 0.5× 12 0.2× 26 313
Giordani Rodrigues dos Passos Brazil 9 262 1.2× 21 0.2× 167 2.1× 85 1.1× 79 1.2× 17 377
Mariska Kooijmans United States 5 527 2.4× 92 0.7× 198 2.5× 211 2.8× 31 0.5× 8 580

Countries citing papers authored by Małgorzata Siger

Since Specialization
Citations

This map shows the geographic impact of Małgorzata Siger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Małgorzata Siger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Małgorzata Siger more than expected).

Fields of papers citing papers by Małgorzata Siger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Małgorzata Siger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Małgorzata Siger. The network helps show where Małgorzata Siger may publish in the future.

Co-authorship network of co-authors of Małgorzata Siger

This figure shows the co-authorship network connecting the top 25 collaborators of Małgorzata Siger. A scholar is included among the top collaborators of Małgorzata Siger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Małgorzata Siger. Małgorzata Siger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Siger, Małgorzata, et al.. (2025). Brain Atrophy and Cognitive Impairment in Primary and Secondary Progressive Multiple Sclerosis Cohort—Similar Progressive MS Phenotype. International Journal of Molecular Sciences. 26(17). 8523–8523.
2.
Siger, Małgorzata, et al.. (2025). Deep learning-based automatic segmentation of brain structures on MRI: A test-retest reproducibility analysis. Computational and Structural Biotechnology Journal. 28. 128–140. 4 indexed citations
3.
Kułakowska, Alina, Dagmara Mirowska-Guzeł, Alicja Kalinowska, et al.. (2024). Disease-modifying therapy in multiple sclerosis: recommendations of Multiple Sclerosis and Neuroimmunology Section of Polish Neurological Society. Neurologia i Neurochirurgia Polska. 58(6). 569–585. 3 indexed citations
4.
Niedziela, Natalia, Alicja Kalinowska, Alina Kułakowska, et al.. (2024). Clinical and therapeutic challenges of smouldering multiple sclerosis. Neurologia i Neurochirurgia Polska. 58(3). 245–255. 5 indexed citations
6.
Niedziela, Natalia, Alicja Kalinowska, Alina Kułakowska, et al.. (2024). „Tlące się stwardnienie rozsiane” — wyzwanie kliniczne i terapeutyczne. 20(2). 89–102.
8.
Siger, Małgorzata, et al.. (2023). Predictive value of brain atrophy, serum biomarkers and information processing speed for early disease progression in multiple sclerosis. Frontiers in Neurology. 14. 1223220–1223220. 5 indexed citations
9.
Siger, Małgorzata. (2022). Magnetic Resonance Imaging in Primary Progressive Multiple Sclerosis Patients. Clinical Neuroradiology. 32(3). 625–641. 15 indexed citations
10.
Matysiak, Mariola, et al.. (2022). The influence of COVID-19 pandemic lockdown on the physical activity of people with multiple sclerosis. The role of online training. Multiple Sclerosis and Related Disorders. 63. 103843–103843. 11 indexed citations
12.
Adamczyk‐Sowa, Monika, Alicja Kalinowska, Małgorzata Siger, et al.. (2021). Diagnostyka stwardnienia rozsianego. Rekomendacje Sekcji Stwardnienia Rozsianego i Neuroimmunologii Polskiego Towarzystwa Neurologicznego. 17(4). 149–164. 2 indexed citations
13.
Zakrzewska‐Pniewska, Beata, Monika Adamczyk‐Sowa, Waldemar Brola, et al.. (2020). Leczenie i postępowanie objawowe w stwardnieniu rozsianym Rekomendacje Sekcji SM i Neuroimmunologii Polskiego Towarzystwa Neurologicznego. 15(4). 191–217. 3 indexed citations
14.
Śmigielski, Janusz, et al.. (2020). Late onset multiple sclerosis — multiparametric MRI characteristics. Neurologia i Neurochirurgia Polska. 54(3). 265–271. 6 indexed citations
15.
Sąsiadek, Marek, Katarzyna Katulska, Agata Majos, et al.. (2018). Guidelines of the Polish Medical Society of radiology for the routinely used MRI protocol in patients with multiple sclerosis. Neurologia i Neurochirurgia Polska. 52(6). 638–642. 2 indexed citations
16.
Walczak, Agata, et al.. (2013). Transdermal Application of Myelin Peptides in Multiple Sclerosis Treatment. JAMA Neurology. 70(9). 1105–1105. 86 indexed citations
17.
Siger, Małgorzata, et al.. (2011). Discontinuation of interferon beta therapy in multiple sclerosis patients with high pre-treatment disease activity leads to prompt return to previous disease activity. Journal of the Neurological Sciences. 303(1-2). 50–52. 29 indexed citations
18.
Siger, Małgorzata, Norbert Schuff, Xiaoping Zhu, Bruce L. Miller, & Michael W. Weiner. (2009). Regional Myo-inositol Concentration in Mild Cognitive Impairment Using 1H Magnetic Resonance Spectroscopic Imaging. Alzheimer Disease & Associated Disorders. 23(1). 57–62. 40 indexed citations
19.
Siger, Małgorzata, et al.. (2009). Cognitive impairment in patients with relapsing-remitting multiple sclerosis. The correlation with MRI lesion volume.. PubMed. 42(5). 416–23. 4 indexed citations
20.
Siger, Małgorzata, et al.. (2008). Optical coherence tomography in multiple sclerosis. Journal of Neurology. 255(10). 1555–1560. 176 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026